American Journal of Transplantation · 2005 · 70 citations · 38 references
MedicineNephrologySurgeryKidney TransplantationRenal Replacement TherapyTransplant SurgeryDeceased Donor Kidney TransplantationDelayed Graft FunctionGraft SurvivalRenal DiseaseTransplant OutcomesTransplant SurvivalAllograft Survival AssessmentCreatinine Clearance MonitoringDonor Kidney Function AssessmentImmediate FunctionImmediate Graft FunctionImpaired Kidney FunctionRecipient Graft SurvivalRenal Dysfunction After Transplant
Nonheart‐beating donor (NHBD) kidneys are frequently associated with delayed graft function (DGF), with a deleterious effect on kidney function and allograft survival. The influence and the duration of DGF on the outcome of NHBD kidneys are assessed.All recipients of an NHBD kidney in the period 1993–2003 were reviewed. Excluded from analysis were patients with primary nonfunction (PNF).One hundred and five patients with a functioning NHBD graft were reviewed: 23 (22%) had immediate function (group 1), 40 (38%) had DGF ≤ 2 weeks (group 2), 31 (30%) had DGF 15 days to 4 weeks (group 3) and 11 (10%) had DGF for >4 weeks (group 4). Creatinine clearance at 3 months was higher in groups 1 and 2 versus group 4 (p = 0.015 and p = 0.006, respectively) and was higher in group 2 versus group 4, at 1 year (p = 0.01). Graft survival was 95%, 98%, 97% and 89%, respectively, at 1 year and 95%, 85%, 77% and 89%, respectively, at 5 years, which was not significantly different.The duration of DGF in NHB kidneys has a negative effect on creatinine clearance, but no effect on graft survival. Nonheart‐beating donor (NHBD) kidneys are frequently associated with delayed graft function (DGF), with a deleterious effect on kidney function and allograft survival. The influence and the duration of DGF on the outcome of NHBD kidneys are assessed. All recipients of an NHBD kidney in the period 1993–2003 were reviewed. Excluded from analysis were patients with primary nonfunction (PNF). One hundred and five patients with a functioning NHBD graft were reviewed: 23 (22%) had immediate function (group 1), 40 (38%) had DGF ≤ 2 weeks (group 2), 31 (30%) had DGF 15 days to 4 weeks (group 3) and 11 (10%) had DGF for >4 weeks (group 4). Creatinine clearance at 3 months was higher in groups 1 and 2 versus group 4 (p = 0.015 and p = 0.006, respectively) and was higher in group 2 versus group 4, at 1 year (p = 0.01). Graft survival was 95%, 98%, 97% and 89%, respectively, at 1 year and 95%, 85%, 77% and 89%, respectively, at 5 years, which was not significantly different. The duration of DGF in NHB kidneys has a negative effect on creatinine clearance, but no effect on graft survival.
38
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen, Kim Solez, Robert B. Colvin et al. · Kidney International · 1999 · 3.1K citations
Medicine, Nephrology, Pathology +17
DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1
Akinlolu Ojo, Robert A. Wolfe, Philip J. Held et al. · Transplantation · 1997 · 995 citations
Categories of non-heart-beating donors.
G. Kootstra, J. H. C. Daemen, A.P.A. Oomen · PubMed · 1995 · 732 citations